1. Stocks
    2. /
  2. Imugene Limited (ASX: IMU)
    3. /

Imugene Limited (ASX: IMU) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Imugene Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

    • Imugene Limited (ASX: IMU)
    Latest News

    Top ten gold trophy.
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The markets went backwards today, but we still had some gains amongst our top shares.

    Read more »

    A man working in the stock exchange.
    Share Market News

    These 6 shares are being kicked out of the ASX 200 index this month

    | James Mickleboro

    Change is afoot for the ASX 200 index.

    Read more »

    A young bearded man wearing a white t-shirt with a yellow backdrop holds up his arms to his chest and points to the camera in celebration of ASX shares rising today
    Share Market News

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    Today made it four-for-four gains in row for the ASX 200.

    Read more »

    cartoon brain standing on winner's block representing rising Brainchip share price
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    The ASX 200 rocketed today, and produced a bevy of big winners.

    Read more »

    A man holds his head in his hands, despairing at the bad result he's reading on his computer.
    Share Market News

    These are the 10 most shorted ASX shares

    | James Mickleboro

    Here's why short sellers are betting on these ASX shares dropping in value.

    Read more »

    A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
    Share Fallers

    Why Centuria Capital, Domain, Imugene, and Telstra shares are falling

    | James Mickleboro

    These ASX shares are ending the week in the red.

    Read more »

    A bored woman looking at her computer, it's bad news.
    Healthcare Shares

    Why is the Imugene share price crashing 15% on Friday?

    | James Mickleboro

    Imugene shares are under pressure on Friday. But why?

    Read more »

    pause in medical asx share price represented by doctor holding hand up in stop motion
    Healthcare Shares

    Here's why the Imugene share price is frozen on Wednesday

    | Bronwyn Allen

    A capital raise is coming...

    Read more »

    Stock market chart in green with a rising arrow symbolising a rising share price.
    Share Gainers

    Here are the top 10 ASX 200 shares today

    | Sebastian Bowen

    It was a cold start to the trading week for the markets today.

    Read more »

    An investor sits at her desk and stretches her arms above her head in delight.
    Share Gainers

    Why Baby Bunting, Carsales, GWA, and Imugene shares are racing higher

    | James Mickleboro

    These ASX shares are starting the week strongly.

    Read more »

    Group of Imugene scientists cheering in the lab after the company received another patent for HER-Vaxx
    Healthcare Shares

    Imugene share price leaps 6% as cancer-killing clinical testing moves forward

    | Bernd Struben

    Imugene’s novel cancer-killing virus just cleared another clinical testing hurdle.

    Read more »

    An investor sits at her desk and stretches her arms above her head in delight.
    Share Gainers

    Why Ampol, Imugene, Mount Gibson Iron, and Renascor shares are pushing higher

    | James Mickleboro

    These ASX shares are on form on Wednesday. But why?

    Read more »

    Frequently Asked Questions

    Imugene does not pay dividends at this stage. 

    Imugene Ltd (ASX: IMU) listed on the ASX on 24 November 1993.

    IMU ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Imugene Limited

    Imugene Ltd (ASX: IMU) is a biotechnology company working in cancer immunotherapy.

    The company specialises in clinical-stage immuno-oncology therapies. Its product pipeline includes Oncolytic Virus and B-Cell Immunotherapies aimed at treating a variety of cancers in combination with standard-care drugs and immunotherapies.

    The company's lead product is HER-Vaxx, a proprietary cancer vaccine for the treatment of gastric and breast cancer, where the cancer is HER-2 positive. The vaccine has demonstrated it stimulates a polyclonal antibody response to HER2/neu. 

    Imugene's various immunotherapy products are involved in ongoing clinical trials involving cancer specialists and researchers worldwide.

    Profile

    since

    Note